GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Accumulated other comprehensive income (loss)

Rubius Therapeutics (STU:5RT) Accumulated other comprehensive income (loss) : €0.00 Mil (As of Dec. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Rubius Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2022 was €0.00 Mil.

Rubius Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Jun. 2022 (€-0.12 Mil) to Sep. 2022 (€0.00 Mil) but then stayed the same from Sep. 2022 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

Rubius Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil) but then stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

Rubius Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Rubius Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Accumulated other comprehensive income (loss) Chart

Rubius Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial -0.03 0.07 - - -

Rubius Therapeutics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.05 -0.12 - -

Rubius Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Rubius Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
CFRX ADTX NBY NBRVF BXRX INM GLMD HSTO BLCM SPRC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
124 Washington Street, Suite 101, Foxborough, MA, USA, 02035
Website
https://www.rubiustx.com
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines